Use of imidazoquinolines for the treatment of EGFR dependent diseases or diseases that have acquired resistance to agents that target EGFR family members

Details for Australian Patent Application No. 2008280105 (hide)

International Classifications

Event Publications

4 February 2010 PCT application entered the National Phase

PCT publication WO2009/013305 Priority application(s): WO2009/013305

20 October 2011 Application Accepted

Published as AU-B-2008280105

16 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.